SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir.

Kanal SinghKevin RubensteinViviane CallierKaty Shaw-SalibaAdam RupertRobin DewarSylvain LaverdureHelene HighbargerPerrine LallemandMeei-Li HuangKeith R JeromeReigran SampoleoMargaret G MillsAlexander L GreningerKavita JunejaDanielle PorterConstance A BensonWalla DempseyHana M El SahlyChris FochtNikolaus JilgCatharine I PaulesRekha R RapakaTimothy M UyekiH Clifford LaneJohn H BeigelLori E Doddnull null

Published in: The Journal of infectious diseases (2024)

Reductions in SARS-CoV-2 RNA and antigen levels in blood correlated with clinical benefit from antiviral therapy.

Keyphrases

sars cov
respiratory syndrome coronavirus
early onset
nucleic acid
coronavirus disease
stem cells
mesenchymal stem cells
bone marrow
adipose tissue